Fighting Diseases

Two Years in: How BRI Continues to Fight COVID-19

Learn about how BRI has helped fight COVID-19 and key questions we’re working to answer moving forward.
Living With A Disease

One Pandemic, Three Autoimmune Diseases and 100 Half Marathons

Gretchen’s goal of running 100 half marathons in 10 years started with doctors telling her what she couldn’t do and ended with her realizing how capable she was.
News & Views

Why COVID-19 Makes It Harder to Predict This Year’s Flu Season

Dr. Uma Malhotra explains what to expect this flu season and how the pandemic may impact it.
News & Views

The Current State of COVID-19: How Dangerous is Delta and Other Key Questions

How dangerous is the Delta variant? Our researchers answer your questions.
Fighting Diseases

BRI and VM Collaboration Sheds Light on Early Predictors of Severe COVID-19

Results from a collaborative study highlight who is most at risk of developing complications from COVID-19.
News & Views

Despite Possible Side Effects, Shoot for the COVID-19 Shot

Two researchers share their experiences with the mRNA vaccines and explain side effects that can occur.
Community Stories

“We’ve Come So Far:” Key Findings and Answers About COVID-19

Drs. Buckner and Lacy-Hulbert recently shared answers to pressing questions about COVID-19 at a Town Hall Seattle event.
News & Views

A Letter From Our President: Latest Advances at BRI

BRI President Jane Buckner shares an update on BRI's work and introduces the new brand.
Fighting Diseases

11 Things to Know About mRNA Vaccines for COVID-19

BRI’s Adam Lacy-Hulbert, PhD explains this innovative vaccination approach.
Fighting Diseases

What Are Clinical Trials? BRI Experts Weigh in On Clinical Research FAQ’s

Members of BRI’s clinical research program answer common questions about clinical research.

Pages